Simplex Trading’s Skye Bioscience SKYE Stock Holding History
Bought
Maintained
Sold
Other funds holding SKYE
BBA
Simplex Trading's SKYE Position: Q3 2026 in Review
Simplex Trading sold out of Skye Bioscience (SKYE) in Q3 2026, closing a stake of 3,372 shares — an estimated $18.7K sold.
Simplex Trading first reported a position in SKYE in Q4 2024 and held it in 4 quarters. The position peaked at $18.7K in Q2 2026. 31 funds tracked by Wall St. Rank hold SKYE as of Q3 2026.
- Simplex Trading reported no remaining Skye Bioscience position as of Q3 2026 after selling out during the quarter.
- Simplex Trading sold 3,372 Skye Bioscience shares in Q3 2026, an estimated $18.7K.
- Simplex Trading first reported a position in Skye Bioscience in Q4 2024 and held it in 4 quarters.
- Simplex Trading's Skye Bioscience position peaked at $18.7K in Q2 2026.
- 31 funds tracked by Wall St. Rank held Skye Bioscience as of Q3 2026.
Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.